You are here: Industry Insights > patient

News List

Window for Safe Use of Clot-Buster, tPA, Widens for Stroke Patients drugs
May 09, 2019
Window for Safe Use of Clot-Buster, tPA, Widens for Stroke Patients.
Less Invasive Mastectomy an Option for More Patients drugs
May 09, 2019
Less Invasive Mastectomy an Option for More Patients.
Brexit's trick or treat on patient safety cphi-online
May 05, 2019
Despite a delayed Brexit, unpredictability adds further complications to the EU FMD regulation.
Interns Spend Most of Their Time in Indirect Patient Care drugs
April 19, 2019
Internal medicine residents spend most of their time participating in indirect patient care, according to research published online in JAMA Internal Medicine.
AZ finds lack of lung cancer info available for patients pharmatimes
April 16, 2019
New AstraZeneca research has shown significant gaps in online sources of information for lung cancer patients.
Report finds NICE unaware of financial interests of patient groups pharmaceutical-technology
January 21, 2019
A report by the London School of Tropical Medicine (LSTM) found that patient organisations consulted by the UK’s National institute of Health and Care Excellence (NICE) to advise on appraisals of medicines and treatments....
Most pharma firms doing little R&D for poorer patients pharmaphorum
December 17, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.....
Amgen partners with Magellan on patient care for difficult-to-treat diseases pharmaceutical-technology
December 13, 2018
Amgen has entered a partnership with Magellan Rx Management to improve care for patients suffering with chronic, difficult-to-treat diseases......
OncoSec Doses First Patient in KEYNOTE-890 Phase 2 Clinical Trial americanpharmaceuticalreview
November 10, 2018
OncoSec announced the first patient has been treated in KEYNOTE-890, a Phase 2 clinical trial for the treatment of late-stage triple negative breast cancer (TNBC) with TAVO (intratumoral plasma encoded IL-12, or tavokinogene telseplasmid, plus electropora
Statement from FDA Commissioner on Updates to FDA’s Expanded Access Program americanpharmaceuticalreview
November 10, 2018
FDA is deeply committed to facilitating this access, while also protecting patients and helping them to be able to make informed decisions with their physicians. We also take steps to help make sure that such access doesn’t interfere or jeopardize investi

Previous page 1 2 3 4 5 Next page